October 18, 2012 ·
Leave a comment
October 18, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement focused on medical centers of excellence in obesity with a top U. S. biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating the condition of obesity, approached Thought Leader Select for support with a variety of collaborative efforts, including medical science liaison outreach to leading universities, medical schools, teaching hospitals, and specialty clinics in this area. Having already worked with Thought Leader Select to form rosters of key opinion leaders in endocrinology, primary care, nursing, pharmacy, and long-term care in the treatment of type I and type II diabetes and obesity, the company has now chosen Thought Leader Select to pinpoint the leading centers of excellence in the treatment of obesity in the United States.
Known for the versatility of applications for its in-house research and analysis, Thought Leader Select’s research group will assess the skills and experience of selected centers, detailing the collaborative activities of leading physicians and other health care professionals, including registered nurses, physician assistants, nurse practitioners, clinical pharmacists, and medical researchers, the people who advance the science of medicine and patient care, through basic and clinical research, scientific journal ... read more »
TAGS: 
basic research biopharmaceutical industry biotechnology Brian Castle centers of excellence identification centers of excellence profiling centers of excellence strategy clinical pharmacists clinical research drug development endocrinology health care professionals key opinion leaders KOL identification KOL profiling KOL strategy long-term care medical device industry medical diagnostics medical researchers medical schools medical science medical science liaison outreach nursing obesity obesity centers of excellence obesity KOLs patient care pharmaceuticals pharmacy physician assistants physicians primary care medicine registered nurses scientific journal publishing specialty medical clinics teaching hospitals Thought Leader Select Thought Leader Select consulting group Thought Leader Select research group treatment guidelines type 1 diatbetes type 2 diabetes universities
September 27, 2012 ·
Leave a comment
(CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in gastroenterology with a top Canadian biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating type and type II diabetes, approached Thought Leader Select for support with scientific advisory boards and continuing health education (CHE) initiatives across multiple Canadian provinces. Having already worked with Thought Leader Select to form a roster of key opinion leaders in Canadian endocrinology circles, the company will round out its roster of key opinion leaders by deploying Thought Leader Select’s team to assess the skills and experiences of registered nurses and clinical pharmacists around the country.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of registered nurses and pharmacists in multiple areas where they collaborate with leading physicians to advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening key opinion leader relationships in the nursing and pharmacy communities, and a suite of tools to promote collaborative work with KOLs.
“Thought ... read more »
TAGS: advisory boards basic research biopharmaceutical biotechnology clinical pharmacists clinical research clinical trials deep-profiling diabetes health care professionals health care providers key opinion leader key opinion leaders KOL KOL engagement KOL identification KOL mapping KOL profiling medical experts Neil Mellor pharmaceuticals registered nurses Thought Leader Select type 1 diabetes type 2 diabetes
January 6, 2011 ·
6 comments
The International Diabetes Federation Atlas (http://www.diabetesatlas.org) reports that 285 million people aged 20-79 years globally have diabetes, a disease impacting most countries. According to the Centers for Disease Control (CDC) 2007 National Diabetes Fact Sheet, diabetes affects 23.6 million people or 7.8% of the U.S. population. It is no wonder, then, that millions of dollars are spent every year to fund research that will treat and perhaps cure the disease.
Certainly, endocrinologists and a host of other specialty physicians participate in basic and clinical research sponsored by government entities, academic institutions, professional societies and biopharmaceutical companies. However, primary care physicians (PCPs) are also widely involved in diabetes research. The diversity of patient populations and illnesses treated by PCPs make them desirable investigators, especially when the research seeks to understand diabetic co-morbidities, how the disease affects different populations, and better ways to help patients manage their diabetes.
Thought Leader Select recently studied the research activities of more than 150 primary care thought leaders (TLs) in the United States and identified several interesting trends about their research activities in general, as well as those related to diabetes research. We found that 86% of primary care TLs are regularly involved in basic and clinical research efforts. Of those 134 actively conducting research, more than half are involved in diabetes-related projects (see Chart 1). More ... read more »
TAGS: academic institutions basic research biopharmaceutical cardiovascular risk CDC Centers for Disease Control chronic disease management clinical research diabetes East Harlem Diabetes Center of Excellence endocrinologists glycemic control International Behavioral Research in Diabetes Group Exchange International Diabetes Federation Atlas key opinion leaders KOL engagement KOL identification KOL profiling KOLs Massachusetts General Hospital Diabetes Clinical Research Center Michigan Diabetes Research and Training Center National Diabetes Fact Sheet obesity patients PCPs pharmaceutical biotechnology physicians primary care physicians professional societies thought leaders type 2 diabetes University of Chicago Diabetes Research and Training Center University of Texas Health Science Ceneter of San Antonio Diabetes Studies VA Quality Enhancement Research Initiative for Diabetes Mellitus Vanderbilt Diabetes Research and Training Center
April 27, 2010 ·
Leave a comment
Thought Leader Select, a North Carolina-based firm dedicated to delivering solutions for key opinion leader identification and deployment for the biopharmaceutical industry, announces the commencement of research on Canadian centers of excellence and the identification of certified diabetes educators for a top-10 global pharmaceutical company.
The client company’s Canadian subsidiary has hired Thought Leader Select to execute two of its industry-standard studies on centers of excellence in health care. For the first contract, the firm will identify and profile 10 centers of excellence in women’s health to aid the company in its development of and launch of medicines to fill imminent women’s health needs.
In the second project, Thought Leader Select will identify and profile 10 centers of excellence in the treatment of Type 2 diabetes. In addition to providing in-depth profiles of the centers and their capabilities for research, clinical practice, and treatment of patients with Type 2 diabetes, the study will also identify and profile 30 non-traditional key opinion leaders, in the form of certified diabetes educators (CDEs). The CDEs are crucial in the execution of the respective centers’ strategies to educate patients with diabetes on a number of treatment options and regimens.
Thought Leader Select will employ the same research methodology, known as deep profiling, that it utilizes in the identification of individual key opinion leaders to perform the work ... read more »
TAGS: biotechnology certified diabetes educators key opinion leader KOL identification KOL management KOL profiling patient education Paul Meade pharmaceutical Thought Leader Select type 2 diabetes women's health
